Author:
Voorhees Peter M,Sborov Douglas W,Laubach Jacob,Kaufman Jonathan L,Reeves Brandi,Rodriguez Cesar,Chari Ajai,Silbermann Rebecca,Costa Luciano J,Anderson Larry D,Nathwani Nitya,Shah Nina,Bumma Naresh,Efebera Yvonne A,Holstein Sarah A,Costello Caitlin,Jakubowiak Andrzej,Wildes Tanya M,Orlowski Robert Z,Shain Kenneth H,Cowan Andrew J,Dinner Shira,Pei Huiling,Cortoos Annelore,Patel Sharmila,Lin Thomas S,Usmani Saad Z,Richardson Paul G
Reference15 articles.
1. DARZALEX® (daratumumab) injection [package insert],2023
2. Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
3. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Dimopoulos;Hemasphere,2021
4. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma;Attal;N Engl J Med,2012
5. Triplet therapy, transplantation, and maintenance until progression in myeloma;Richardson;N Engl J Med,2022